Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vext ScienceFRA:VV5 -36.03%62 Days Inventory is 109.62 as of Mar. 2026, which is 390% above its 10-year median of 22.36. GuruFocus rates FRA:VV5 with a GF Score™ of 62/100 and a GF Value™ of €0.92. The stock has 3 warning signs investors should review. Among 923 Drug Manufacturers companies, Vext Science ranks better than 79.96% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Vext Science's Average Total Inventories for the
three
months ended in Mar. 2026 was €6.90 Mil. Vext Science's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €5.74 Mil.
Hence, Vext Science's Days Inventory for the
three
months ended in Mar. 2026 was 109.62.
The historical rank and industry rank for Vext Science's Days Inventory or its related term are showing as below:
FRA:VV5'
s Days Inventory Range Over the Past 10 Years
Min: 2.24 Med: 22.36 Max: 217.92
Current: 99.55
During the past 9 years, Vext Science's highest Days Inventory was 217.92. The lowest was 2.24. And the median was 22.36.
FRA:VV5's Days Inventory is ranked better than 79.96% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs FRA:VV5: 99.55
Vext Science's Days Inventory
declined
from Mar. 2025 (118.64) to Mar. 2026 (109.62).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vext Science's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.83.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vext Science's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.66.
Vext Science (FRA:VV5) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vext Science's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vext Science's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vext Science Days Inventory Related Terms
Vext Science Days Inventory Historical Data
* Premium members only.
The historical data trend for Vext Science's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vext Science's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vext Science Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vext Science's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vext Science's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vext Science (FRA:VV5) has a Days Inventory of 109.62 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vext Science and its competitors. This is 390% above median its historical median of 22.36. Over the past decade, Vext Science's Days Inventory has ranged from 2.24 to 217.92. According to the industry distribution chart, Vext Science ranks #185 out of 923 companies in the Drug Manufacturers industry, placing it in the top 20%.
Is Vext Science's Days Inventory too high?
Vext Science's current Days Inventory of 109.62 is 390% above median its 10-year median of 22.36. Over the past 10 years, this metric has ranged from a low of 2.24 to a high of 217.92. The Drug Manufacturers industry median Days Inventory is 164.48. Vext Science's value of 109.62 is 33.4% below this industry median. Based on the distribution chart, Vext Science ranks #185 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vext Science has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Vext Science's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vext Science ranks #185 out of 923 companies for Days Inventory. This places Vext Science in the top 20% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. Vext Science's value of 109.62 is 33.4% below this benchmark. Historically, Vext Science's own Days Inventory has ranged from 2.24 to 217.92 over the past decade. While the company's 10-year median is 22.36 vs. the industry median of 164.48, Vext Science has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vext Science's current Days Inventory of 109.62 is 33.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vext Science and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vext Science's current Days Inventory is 109.62, which is 390% above median its own 10-year median of 22.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vext Science stock overvalued right now?
Vext Science (FRA:VV5) has a current Days Inventory of 109.62. The stock's GF Value™ is €0.92, compared to a current price of €0.09 — trading 90.5% below its estimated fair value. The current Days Inventory is 109.62, which is 390% above median its 10-year median of 22.36 and 33.4% below the Drug Manufacturers industry median of 164.48. Vext Science's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vext Science (FRA:VV5), the current Days Inventory is 109.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vext Science (FRA:VV5) Overvalued in 2026?
Based on GuruFocus' analysis, Vext Science stock appears to be undervalued.
The current stock price of €0.09 is trading 90.5% below its estimated GF Value™ of €0.92.
Key valuation signals for FRA:VV5:
Days Inventory: 109.62 (390% above median its 10-year median of 22.36)
GF Value™: €0.92 vs. price of €0.09 (90.5% below fair value)
Industry Position: 33.4% below the Drug Manufacturers median (#185 of 923)
No single metric tells the full story. See the FRA:VV5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vext Science Inc engages in the full spectrum of the cannabis product lifecycle, from development and manufacturing to distribution. Its brands include Herbal Wellness, Appalachian Pharm, Revibe, Prism, Vapen, and Firebrand. In Arizona and Ohio, the dispensaries operate under the Herbal Wellness Center brand, while in Ohio the cultivation and manufacturing operations are licensed and branded as Appalachian Pharms Cultivation and Appalachian Pharm Processing. The Company operates through a single operating segment engaged in the cultivation, manufacturing, distribution, and sale of cannabis within the United States. All revenues are generated in the United States.
62GF Score
Get the complete analysis for FRA:VV5
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VV5 has been successfully added to your 
